|
Market Closed -
Nasdaq
00:00:00 27/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 553.44 USD | +0.62% |
|
+0.02% | -18.19% |
| 08-18 | IDEXX Laboratories, Inc. - Analyst/Investor Day | |
| 08-11 | IDEXX Laboratories Launches Catalyst proBNP Test for In-Clinic Cardiac Disease Assessment | MT |
Chart: Technical Analysis
Stock exchange
Nasdaq
IDXX 553.44 $
+0.62%
193M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| IDXX | 553.44USD | +0.62% | 193M $ | |
CBOE
| IDXX | 553.33USD | +0.63% | 7.57M $ | |
Tradegate
| IX1 | 474.80EUR | +0.79% | 42.73K € | |
Mexican S.E.
| IDXX * | 9,483.00MXN | -8.82% | 578K $ | |
London S.E.
| 0J8P | 581.90USD | +2.75% | 20.37K $ | |
Xetra
| IX1 | 479.90EUR | +2.52% | 9.6K € | |
Wiener Boerse
| IDXX | 476.20EUR | +0.57% | 6.67K € | |
Boerse Muenchen
| IX1 | 475.30EUR | +0.74% | 3.8K € | |
Deutsche Boerse AG
| IX1 | 476.00EUR | -0.46% | 476 € | |
Börse Stuttgart
| IX1 | 475.30EUR | +0.98% | 0 € | |
Berne S.E.
| IX1 | 443.61CHF | +0.20% | 0 CHF | |
Borsa Italiana
| 1IDXX | 472.50EUR | -0.78% | 0 € | |
Sao Paulo
| I1DX34 | 572.47BRL | -2.06% | 2.86K R$ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bearish |
| Resistance | 595.76 | 660.71 | 629.35 |
| Spread/Res. | -7.10% | -16.24% | -12.06% |
| Spread/Supp. | +2.61% | +5.13% | +4.66% |
| Support | 539.36 | 526.44 | 528.79 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- IDXX Stock
- Charts IDEXX Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions

















